GENELUX Corp
GNLX · XNASCIK 1231457fmd_0T40HWR377EXFG9N6PW0PXZ0P6Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2022 to Jun 30, 2026, 18 periods
Latest annual · FY2025
Millions- Total revenues
- 0
- Operating income
- (33)
- Net income
- (32)
- Free cash flow
- (26)
Latest quarter · Q2 FY2026
Millions- Operating income
- (10)
- Net income
- (9)
- Free cash flow
- (8)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2022 to FY2025
- -91.0%
GENELUX Corp (GNLX) financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2025 | FY2024 | Change | Source |
|---|---|---|---|---|
| Revenue | $8,000 | $8,000 | 0% | 10-K 2026-03-19 · proof |
| Operating income | -$33.2 million | -$31.7 million | 10-K 2026-03-19 · proof | |
| Net income | -$32.1 million | -$29.9 million | 10-K 2026-03-19 · proof | |
| Cash from operating activities | -$25.3 million | -$21.2 million | 10-K 2026-03-19 · proof | |
| Free cash flow | -$26.4 million | -$21.6 million | 10-K 2026-03-19 · proof | |
| Total assets | $19 million | $34.7 million | -45.2% | 10-K 2026-03-19 · proof |
| Total liabilities | $7.5 million | $8.4 million | -11.4% | 10-K 2026-03-19 · proof |
| Cash and cash equivalents | $5.3 million | $8.6 million | -37.7% | 10-K 2026-03-19 · proof |
- What was GENELUX Corp (GNLX)'s revenue in fiscal 2025?
- GENELUX Corp (GNLX) reported revenue of $8,000 for fiscal 2025 (the year ended Dec 31, 2025), against $8,000 the year before (0%). Source: the 10-K filed with the SEC on Mar 19, 2026. SEC
- What was GENELUX Corp (GNLX)'s operating income in fiscal 2025?
- GENELUX Corp (GNLX) reported operating income of -$33.2 million for fiscal 2025 (the year ended Dec 31, 2025), against -$31.7 million the year before. Source: the 10-K filed with the SEC on Mar 19, 2026. SEC
- What was GENELUX Corp (GNLX)'s net income in fiscal 2025?
- GENELUX Corp (GNLX) reported net income of -$32.1 million for fiscal 2025 (the year ended Dec 31, 2025), against -$29.9 million the year before. Source: the 10-K filed with the SEC on Mar 19, 2026. SEC
- What was GENELUX Corp (GNLX)'s cash from operating activities in fiscal 2025?
- GENELUX Corp (GNLX) reported cash from operating activities of -$25.3 million for fiscal 2025 (the year ended Dec 31, 2025), against -$21.2 million the year before. Source: the 10-K filed with the SEC on Mar 19, 2026. SEC
- What was GENELUX Corp (GNLX)'s free cash flow in fiscal 2025?
- GENELUX Corp (GNLX) reported free cash flow of -$26.4 million for fiscal 2025 (the year ended Dec 31, 2025), against -$21.6 million the year before. Source: the 10-K filed with the SEC on Mar 19, 2026. SEC
- What are GENELUX Corp (GNLX)'s total assets?
- As of Dec 31, 2025, GENELUX Corp (GNLX) reported total assets of $19 million, against $34.7 million a year earlier (-45.2%). Source: the 10-K filed with the SEC on Mar 19, 2026. SEC
- What are GENELUX Corp (GNLX)'s total liabilities?
- As of Dec 31, 2025, GENELUX Corp (GNLX) reported total liabilities of $7.5 million, against $8.4 million a year earlier (-11.4%). Source: the 10-K filed with the SEC on Mar 19, 2026. SEC
- What are GENELUX Corp (GNLX)'s cash and cash equivalents?
- As of Dec 31, 2025, GENELUX Corp (GNLX) reported cash and cash equivalents of $5.3 million, against $8.6 million a year earlier (-37.7%). Source: the 10-K filed with the SEC on Mar 19, 2026. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:GNLX&period_type=annual&limit=5"Information only, not investment advice.